Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission

Wiley - Tập 50 Số 1 - Trang 36-42 - 2004
Esmeralda Molenaar1, Alexandre E. Voskuyl, Huib J Dinant, P.D. Bezemer, Maarten Boers, Ben A. C. Dijkmans
1VU University Medical Center, Amsterdam, The Netherlands

Tóm tắt

AbstractObjectiveTo assess whether radiologic progression occurs during clinical remission in patients with rheumatoid arthritis (RA).MethodsOne hundred eighty‐seven patients with RA in clinical remission were followed up clinically and radiologically for 2 years. Clinical remission was defined according to a modification of the American College of Rheumatology criteria (i.e., the criterion of fatigue was omitted, and patients had to fulfill 4 of the 5 remaining criteria). Radiologic joint damage was assessed by the Sharp/van der Heijde method.ResultsAfter 2 years of followup, remission persisted in 52% of patients. The median radiologic score for the total group of patients increased from 21 (interquartile range [IQR] 5, 65) at the time of entry to 25 (IQR 7, 72) after 2 years (P < 0.001). The median score for radiologic progression between baseline and 2 years was 0.5 (IQR 0, 2.5). Among patients with an exacerbation of RA (n = 86), the median score for progression over 2 years was 1.0 (IQR 0, 4.5) (P < 0.001), and in patients with a persistent remission (n = 93) it was 0 (IQR −0.5, 2.0) (P < 0.001). Clinically relevant progression of damage was more frequent in patients with exacerbation (23%) than in those with persistent remission (7%) (P = 0.001). However, in 15% of patients with persistent remission, an erosion developed in a previously unaffected joint. In the logistic regression analysis, the area under the curve of the Disease Activity Score, a continuous measure, was related to the chance of radiologic progression, regardless of the absolute disease activity level. Results were similar when other definitions of remission were used.ConclusionAlthough rare, clinically relevant progression of joint damage does occur in patients with RA in prolonged remission. This suggests the need for markers that predict progression during periods of low disease activity and for drugs that prevent damage that is independent of disease activity.

Từ khóa


Tài liệu tham khảo

Van Zeben D, 1994, The severity of rheumatoid arthritis: a 6‐year followup study of younger women with symptoms of recent onset, J Rheumatol, 21, 1620

Wolfe F, 1996, The natural history of rheumatoid arthritis, J Rheumatol, 44, 13

10.3109/03009748909092612

10.1002/1529-0131(199809)41:9<1571::AID-ART7>3.0.CO;2-R

10.1093/rheumatology/36.2.225

10.1093/rheumatology/35.12.1263

10.1002/art.1780390116

10.1002/art.1780241012

10.1093/rheumatology/35.11.1101

Wolfe F, 1985, Remission in rheumatoid arthritis, J Rheumatol, 12, 245

10.1093/rheumatology/35.11.1096

10.1093/rheumatology/37.12.1324

10.1016/S0140-6736(96)90535-8

10.1002/art.1780310302

10.1093/rheumatology/39.7.742

10.1002/art.1780360601

Ritchie DM, 1968, Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis, Q J Med, 37, 393

10.1007/BF02032335

10.1136/ard.49.11.916

10.1002/art.1780301102

10.1016/S0140-6736(89)92442-2

Shrout PE, 1979, Intraclass correlations: uses in assessing rater reliability, Psychol Bull, 86, 720, 10.1037/0033-2909.86.2.420

Lassere MN, 2001, Robustness and generalizability of smallest detectable difference in radiological progression, J Rheumatol, 28, 911

10.1016/S0140-6736(97)01300-7

10.1056/NEJM200011303432202

10.1056/NEJM200011303432201

Van Zeben D, 1993, Factors predicting outcome of rheumatoid arthritis: results of a follow‐up study, J Rheumatol, 20, 1288

Garnero P, 2002, Short‐term reduction in urinary CTX‐II, a marker of cartilage degradation, predicts long‐term radiological progression in patients with rheumatoid arthritis (RA) treated with disease‐modifying antirheumatic therapy (DMARD), Arthritis Rheum, 46, S376

10.1002/art.10616